Vindesine Sulfate Market Size, Share and Trends Analysis Report, By Application (Lung Cancer, Breast Cancer, Esophageal Cancer, Malignant Lymphoma, and Others), By End-user (Hospitals, Speciality Clinics, Others), Forecast (2022-2028)

The global vindesine sulfate market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). Vindesine sulfate is an alkaloid sulfate salt that plays an important role as an antineoplastic agent in the treatment of several cancers including lung cancer, breast cancer, esophageal cancer, and others. The major factor attributing to the growth of the global vindesine sulfate market includes increasing cases of breast cancer across the globe. According to the report published by the World Health Organization (WHO), around 2.3 million women were diagnosed with breast cancer globally in 2020 with a mortality of around 6,85,000 women. The report also describes that at the end of 2020, around 7.8 million women are living with breast cancer across the globe. Furthermore, the rising prevalence of lung cancer is also increasing the demand for vindesine sulfate for its treatment. According to the American Lung Association, around 5,41,000 people in the US are living with lung cancer in 2020. The mortality due to lung cancer is estimated to be around 25% of all mortality due to cancer.

In addition, the increasing cases of esophageal cancer are also boosting the demand for vindesine sulfate for its treatment. According to the American Cancer Society (ACS), around 20,640 new esophageal cancer cases are estimated to be diagnosed in 2022 in the US alone. The mortality due to esophageal cancer is estimated at around 16,410 in the US in 2022. Among these, around 13,250 mortality is in men, and around 3,160 mortality is estimated to be in women.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Application
  • By End-user
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Pfizer Inc., Eli Lilly & Co., Minfin sprl, Shanghai New Hualian Pharmaceutical Co. Ltd., and Min Sheng He Pte Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Vindesine Sulfate  Market Report by Segment

By Application

• Lung Cancer
• Malignant Lymphoma
• Breast Cancer
• Esophageal Cancer
• Others

By End-user

• Hospitals
• Speciality Clinics
• Others

Global Vindesine Sulfate  Market Report by Region

North America

• The United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa